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Most women take calcium (Ca) supplementation for the preven-
tion or treatment of osteoporosis at or beyond the onset of the
menopause (S i n g h et al., 2000). At the same time, this group
is faced with an increased risk of thyroid disorders such as sec-
ondary and tertiary hypothyroidism (S u c h a r t w a t n a -
c h a i et al., 2002; S c h i n d l e r, 2003). According to differ-
ent studies, thyroid functioning decreases with advancing age,
affecting the whole hypothalamo-pituitary-thyroid axis in both
humans and rats (R o b u s c h i et al., 1987; R e y m o n d et
al., 1992). Rodents are considered to be useful models for thy-
roid studies, even though significant differences between rodent
and human thyroid physiology have been reported (P o i r i e r
et al., 1999). 
Implemented Ca treatment can affect thyroid functioning
by various mechanisms that do not exclude each other. It can act
indirectly, by influencing the regulatory pituitary TSH cells
(G i l l e t et al., 1990; B e r g e n f e l z et al., 1994), as well as
by altering the level of peripheral conversion of T4 to T3 (E t -
l i n g et al., 1986). Calcium can also influence activity of thy-
roid follicular cells directly, by modulating the TSH stimulato-
ry effect (G e b e r s c e k et al., 1998; V a n v o o r e n et al.,
2000).
We previously demonstrated that chronic Ca administra-
tion to middle-aged female rats affects the immunohistochemi-
cal, histological, and morphometrical features of pituitary thy-
rotrophic cells and thyroid tissue (S e k u l i ć et al., 1998; Š o -
š i ć - J u r j e v i ć et al., 2005). As a continuation of these in-
vestigations, in the present study we examined the effects of Ca
administration on serum levels of thyrotropin (TSH), total thy-
roxine (T4), and triiodothyronine (T3) hormones in the same
middle-aged rat model.
Female Wistar rats (14-month-old) were maintained under
standard laboratory conditions (22 ± 2 °C, 12-h light/dark peri-
ods) with free access to food and water. A group of animals (Ca;
n = 6) received intramuscularly 28.55 mg/ kg b.w. Ca-glubion-
ate (Novartis, Nyon, Switzerland) once a day for two weeks ev-
ery day except on Sundays. Age-matched controls (C, n = 6)
were treated with an equivalent volume of physiological saline.
Experimental protocols were approved by the Local Animal
Care Committee and conform to the recommendations given in
the “Guide for the Care and Use of Laboratory Animals” (1996,
National Academy Press, Washington D.C.). All animals were
sacrificed 24 h after the last injection. Sera were separated from
trunk blood after decapitation and stored at -70°C. To determine
the serum concentration of TSH, total T4, and T3, ELISA assays
were employed using a commercial human test kit (HUMAN,
Wiesbaden, Germany). All serum samples were measured with-
in the same assay in duplicate. The intra assay coefficient of
variation was 5.0-13.8% for TSH, 9. 8-8.7% for T4, and 13.2-
7.7% for T3 (low and high sample levels). All results were ex-
pressed as the mean ± SD. Student’s t-test was used for compar-
ative evaluation. The minimum level of significance was set at
p<0.05.
The mean serum concentrations of TSH, T4, and T3 in the
control and Ca-treated groups are summarized in Fig. 1 (a-c).
Chronic Ca administration to middle-aged female rats brought
about a decrease of all of the examined serum parameters in
comparison with the vehicle-treated control values: (i) the se-
rum level of TSH decreased by 30.6%, p<0.005 (Fig. 1a); (ii)
the serum level of T4 decreased by 19%, p<0.025 (Fig. 1b); and
(iii) the serum level of T3 decreased by 22%, p<0.05 (Fig. 1c).
These results clearly demonstrate that thyroid functioning
decrease after chronic administration of Ca to middle-aged fe-
male animals. 
The treatment promoted a striking reduction of serum TSH
concentration. This is consistent with our previous findings that
Ca supplementation brings about a decrease of the examined
stereological parameters for pituitary TSH cells – the relative
cellular volume and the relative percentage of thyrotropes with-
in the pituitary unit volume in middle-aged female rats (S e -
k u l i ć et al., 1998). G i l l e t et al., (1990) also found that
acute and chronic hypercalcemia leads to a decrease of TSH se-
cretion in males.It follows that, Ca treatment can affect thyroid
functioning indirectly, by reducing level of its major stimulato-
ry factor, pituitaryTSH. In contrast to our findings, K a l i š n i k
et al. (1990) reported increased thyroid functioning to be ac-
companied by a decreased TSH concentration in adult rats. This
discrepancy could be due to the different ages of the examined
experimental animals.
Under our experimental conditions, a significant decrease
of serum T4 and T3 was also detected. These results can be at-
tributed to the above mentioned decrease of TSH, since the giv-
en hormone acts as a major positive factor in the regulation of
thyroid functioning. Our previous morphometric research on
thyroid gland structure showed that Ca administration signifi-
cantly decreases volumetric density of the thyroid follicular cell
epithelium, as well as its height and index of activation rate
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(Š o š i ć - J u r j e v i ć et al., 2002). In vitro studies with
FTRL-5 cells demonstrated that Ca does not affect the morphol-
ogy of these cells, but acts directly when administered together
with TSH by reducing the thyrotrophin stimulatory effect (G a -
b e r s c e k et al., 1998). V a n v o o r e n et al. (2000) found
that isoform VI of adenylyl cyclase, the enzyme crucial for
TSH-induced activation of thyroid follicular cells, is negatively
modulated by Ca in human and dog thyroids.
The present study also showed that Ca supplementation de-
creases the serum concentration of total T3 to a greater extent
than the concentration of T4. This is consistent with the findings
of E t l i n g et al. (1986), who showed that dietary calcium in-
hibits the conversion of T4 toT3 in the serum, as well as in the
liver and kidneys of rats.
It can be concluded that Ca administration exerts an ad-
verse effect on thyroid functioning in middle-aged female rats,
indirectly and/or directly. However, the mechanisms underlying
the observed effect are still unclear.
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Fig. 1. Serum level of TSH (Fig. 1a), total T4 (Fig. 1b), and T3 (Fig. 1c)
in control (C; n = 6) and Ca-treated (Ca; n = 6) middle-aged female rats.
Results are means ± SD. o p<0.05, oo p<0.025, *** p<0.001.
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